PHARMACEUTICAL COMPOSITIONS AND USE THEREOF Russian patent published in 2020 - IPC A61K31/513 A61P35/00 

Abstract RU 2712187 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: presented group of inventions refers to pharmaceutical industry, namely to an agent for treating cancer. Pharmaceutical composition for treating cancer, comprising: micronized particles of compound A and/or micronized particles of at least one pharmaceutically acceptable salt of compound A and at least one pharmaceutically acceptable excipient, wherein said micronised particles of compound A and/or micronized particles of at least one pharmaceutically acceptable salt of compound A have particle size distribution (PSD) D90 of less than or equal to 20 mcm, wherein said compound A is N-(2-(dimethylamino)ethyl)-1-(3-((4-((2-methyl-1H-indol-5-yl)oxy)pyrimidin-2-yl)amino)phenyl)methanesulphonamide, presented by formula

(embodiments).

Use of the pharmaceutical composition for preparing a drug for treating cancer. Micronized particles of compound A and/or micronized particles of at least one pharmaceutically acceptable salt of compound A (embodiments). Use of micronized particles of compound A for preparing a drug for treating cancer. Method of treating a subject for which the need to treat cancer is recognized, comprising administering to an individual in need thereof an effective amount of a pharmaceutical composition or micronized particles of compound A.

EFFECT: compositions described above and micronized particles of compound A are characterized by high AUC value in the dosage form, low toxicity, using them reducing cases of vomiting in treating cancer diseases.

26 cl, 8 dwg, 12 tbl, 4 ex

Similar patents RU2712187C2

Title Year Author Number
PHARMACEUTIC COMPOSITION CONTAINING OMAGACARBOXYARYL-SUBSTITUTED DIPHENYL UREA FOR CANCER TREATMENT 2006
  • Shjukler Fritts
  • Vollenshleger Aksel'
RU2420283C2
SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUBSTITUTED INDANE, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF 2019
  • Lindemann, Christopher
  • Stengel, Peter J.
RU2772693C1
POLYMORPHIC FORMS OF ST-246 COMPOUND AND METHODS FOR PRODUCING 2011
  • Tjavanagimatt Shantkhakumar R.
  • Stoun Melialani A.K.L.
  • Uejmers Uilljam K.
  • Nelson Dilan
  • Bolken Touv K.
  • Khrubi Dennis E.
  • O'Nejll Majkl Kh.
  • Sviteppl Gari
  • Makklun Kelli A.
RU2578606C2
LOW-DOSE PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN FOR ORAL ADMINISTRATION 2015
  • Madan Kharish Kumar
  • Venkateshvaran Ratinasabapati
  • Madan Sumit
  • Kochkhar Ravi
RU2707753C2
PHARMACEUTICAL COMPLEX COMPOSITION CONTAINING AMLODIPINE, LOSARTAN AND ROSUVASTATIN 2016
  • Kim, Yong Il
  • Im, Ho Taek
  • Cho, Hyuk Jun
  • Yoon, Youngsu
  • Park, Jae Hyun
  • Woo, Jong Soo
RU2724338C2
METHODS OF INHIBITING LEUCOTREEN-A-HYDROLASES 2014
  • Springmen Erik B.
  • Pyu Margaret Makkrenn
  • Batt Lopa
  • Grossvald Ralf
RU2686101C2
COMPOSITIONS AND METHODS OF TREATING ANDROGEN-RECEPTOR-POSITIVE CANCER 2020
  • Caligiuri, Maureen
  • Ericsson, Anna
  • Guichard, Sylvie
  • Xu, Qunli
RU2817802C2
PHARMACEUTICAL COMPOSITIONS OF SUBSTITUTED QUINAZOLINONES 2012
  • Shinoj Narmada R.
RU2640115C2
PHARMACEUTICAL COMPOSITION CONTAINING PARP INHIBITORS 2019
  • Xu, Jiajia
  • Chen, Hao
  • Wang, Xu
RU2785677C1
SOLID PHARMACEUTICAL PREPARATION, METHOD OF ITS PREPARATION AND USE 2021
  • Tszyan, Taotao
  • Van, Tszibyao
  • Yan, Khan
  • Li, Li
  • Dan, Chzhaolin
  • Chzhu, Kei
  • Tszen, Chzhenya
  • Su, Bo
  • Chen, Si
RU2809722C1

RU 2 712 187 C2

Authors

Lyu Chzhunchzhou

Fu Chundun

Shi Bin

Dates

2020-01-24Published

2016-05-24Filed